Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction

IMPORTANCE: Men with metastatic prostate cancer who have a poor response to initial androgen-deprivation therapy (ADT), as reflected by a prostate-specific antigen (PSA) level higher than 4.0 ng/mL after 7 months of ADT, have a poor prognosis, based on historical controls. OBJECTIVE: To determine th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA Oncol
Hauptverfasser: Flaig, Thomas W., Plets, Melissa, Hussain, Maha H. A., Agarwal, Neeraj, Mitsiades, Nicholas, Deshpande, Hari A., Vaishampayan, Ulka N., Thompson, Ian M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Medical Association 2017
Schlagworte:
Original Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824213/
https://ncbi.nlm.nih.gov/pubmed/28358937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.0231
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge